Duquesne Family Office’s Zai Lab ZLAB Stock Holding History

Duquesne Family Office’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-20,570	Closed	-$1.71M	–	80
2020 Q3	$1.71M	Buy	+20,570	New	+$1.65M	0.05%	61

Other funds holding ZLAB

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BAM

Brilliance Asset Management Admiralty, Hong Kong, Hong Kong $339M AUM 9.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Duquesne Family Office's ZLAB Position: Q4 2020 in Review

Duquesne Family Office sold out of Zai Lab (ZLAB) in Q4 2020, closing a stake of 20,570 shares — an estimated $1.71M sold.

Duquesne Family Office first reported a position in ZLAB in Q3 2020 and held it in 1 quarter. The position peaked at $1.71M in Q3 2020. 191 funds tracked by Wall St. Rank hold ZLAB as of Q4 2020.

Duquesne Family Office reported no remaining Zai Lab position as of Q4 2020 after selling out during the quarter.
Duquesne Family Office sold 20,570 Zai Lab shares in Q4 2020, an estimated $1.71M.
Duquesne Family Office first reported a position in Zai Lab in Q3 2020 and held it in 1 quarter.
Duquesne Family Office's Zai Lab position peaked at $1.71M in Q3 2020.
191 funds tracked by Wall St. Rank held Zai Lab as of Q4 2020.

Based on Duquesne Family Office's 13F filing for Q4 2020, filed 16 Feb 2021.